Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $222B |
| FY2017, ended Dec 31, 2017 | $302B |
| FY2018, ended Dec 31, 2018 | $238B |
| FY2019, ended Dec 31, 2019 | $307B |
| FY2020, ended Dec 31, 2020 | $262B |
| FY2021, ended Dec 31, 2021 | $359B |
| FY2022, ended Dec 31, 2022 | $265B |
| FY2023, ended Dec 31, 2023 | $265B |
| FY2024, ended Dec 31, 2024 | $334B |
| FY2025, ended Dec 31, 2025 | $395B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $398B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $83.7B |
| FY2017, ended Dec 31, 2017 | $87.1B |
| FY2018, ended Dec 31, 2018 | $91.0B |
| FY2019, ended Dec 31, 2019 | $91.2B |
| FY2020, ended Dec 31, 2020 | $85.5B |
| FY2021, ended Dec 31, 2021 | $89.1B |
| FY2022, ended Dec 31, 2022 | $95.0B |
| FY2023, ended Dec 31, 2023 | $103B |
| FY2024, ended Dec 31, 2024 | $106B |
| FY2025, ended Dec 31, 2025 | $113B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $119B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income |
|---|---|
| FY2016, ended Dec 31, 2016 | $17.8B |
| FY2017, ended Dec 31, 2017 | $18.2B |
| FY2018, ended Dec 31, 2018 | $28.1B |
| FY2019, ended Dec 31, 2019 | $27.4B |
| FY2020, ended Dec 31, 2020 | $17.9B |
| FY2021, ended Dec 31, 2021 | $32.0B |
| FY2022, ended Dec 31, 2022 | $27.5B |
| FY2023, ended Dec 31, 2023 | $26.3B |
| FY2024, ended Dec 31, 2024 | $27.0B |
| FY2025, ended Dec 31, 2025 | $30.5B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $33.6B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $148B |
| FY2017, ended Dec 31, 2017 | $157B |
| FY2018, ended Dec 31, 2018 | $177B |
| FY2019, ended Dec 31, 2019 | $162B |
| FY2020, ended Dec 31, 2020 | $380B |
| FY2021, ended Dec 31, 2021 | $348B |
| FY2022, ended Dec 31, 2022 | $230B |
| FY2023, ended Dec 31, 2023 | $333B |
| FY2024, ended Dec 31, 2024 | $290B |
| FY2025, ended Dec 31, 2025 | $232B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $230B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $241B |
| FY2017, ended Dec 31, 2017 | $260B |
| FY2018, ended Dec 31, 2018 | $250B |
| FY2019, ended Dec 31, 2019 | $265B |
| FY2020, ended Dec 31, 2020 | $282B |
| FY2021, ended Dec 31, 2021 | $304B |
| FY2022, ended Dec 31, 2022 | $286B |
| FY2023, ended Dec 31, 2023 | $315B |
| FY2024, ended Dec 31, 2024 | $307B |
| FY2025, ended Dec 31, 2025 | $338B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $400B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 30.2% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 10.0B |
| FY2017, ended Dec 31, 2017 | 10.2B |
| FY2018, ended Dec 31, 2018 | 9.66B |
| FY2019, ended Dec 31, 2019 | 8.73B |
| FY2020, ended Dec 31, 2020 | 8.63B |
| FY2021, ended Dec 31, 2021 | 8.07B |
| FY2022, ended Dec 31, 2022 | 8.00B |
| FY2023, ended Dec 31, 2023 | 7.87B |
| FY2024, ended Dec 31, 2024 | 7.60B |
| FY2025, ended Dec 31, 2025 | 7.18B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 6.99B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $5.11B | $1.37B |
| FY2017, ended Dec 31, 2017 | $12.8B | $1.65B |
| FY2018, ended Dec 31, 2018 | $20.1B | $1.73B |
| FY2019, ended Dec 31, 2019 | $28.1B | $1.97B |
| FY2020, ended Dec 31, 2020 | $7.03B | $2.03B |
| FY2021, ended Dec 31, 2021 | $25.1B | $2.77B |
| FY2022, ended Dec 31, 2022 | $5.07B | $2.86B |
| FY2023, ended Dec 31, 2023 | $4.58B | $2.94B |
| FY2024, ended Dec 31, 2024 | $13.1B | $3.43B |
| FY2025, ended Dec 31, 2025 | $21.4B | $4.00B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $24.9B | $4.14B |
Valuation
At current price- Market Cap
- $354B
- P/E
- 10.5×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.0×
- Price / Book
- 1.2×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $119B
- Revenue Growth YoY
- 8.1%
- Revenue CAGR 3Y
- 6.0%
- Revenue CAGR 5Y
- 5.7%
- EPS Growth YoY
- 27.7%
- Net Income Growth YoY
- 20.4%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- —
- Net Margin
- 28.2%
- FCF Margin
- —. Free cash flow / revenue
- Return on Equity
- 11.2%
Earnings
Trailing 12 months- Net Income
- $33.6B
- EPS (diluted)
- $4.33
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $230B
- Total Debt
- $400B
- Net Debt
- $170B
- Total Assets
- $3.50T
- Total Liabilities
- $3.20T
- Shareholders' Equity
- $301B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $94.7B
- Capital Expenditure
- —
- Free Cash Flow
- —. Operating cash flow − capital expenditure
Dividends and risk
Last 12 months- Dividend Yield
- 2.3%
- Dividend / Share
- $1.16
- Beta (5Y)
- 1.21
Every ratio is calculated from the company’s reported figures.